ZTS Zoetis Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ZTS

Price (delayed)

$154.75

Market cap

$72.44B

P/E Ratio

35.01

Dividend/share

$1.23

EPS

$4.42

Enterprise value

$76.53B

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
The P/E is 26% lower than the last 4 quarters average of 46.4 and 18% lower than the 5-year quarterly average of 41.6
Zoetis's EPS has increased by 10% YoY
Zoetis's quick ratio has decreased by 44% YoY and by 10% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.zoetis.com/
Peers: LLY MRK PFE PAHC

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
468.14M
Market cap
$72.44B
Enterprise value
$76.53B
Valuations
Price to earnings (P/E)
35.01
Price to book (P/B)
15.9
Price to sales (P/S)
9.1
EV/EBIT
27.53
EV/EBITDA
23.63
EV/Sales
9.57
Earnings
Revenue
$8B
EBIT
$2.78B
EBITDA
$3.24B
Free cash flow
$1.43B
Per share
EPS
$4.42
Free cash flow per share
$3.04
Book value per share
$9.73
Revenue per share
$17.01
TBVPS
$20.55
Balance sheet
Total assets
$13.77B
Total liabilities
$9.19B
Debt
$6.73B
Equity
$4.58B
Working capital
$3.6B
Liquidity
Debt to equity
1.47
Current ratio
2.18
Quick ratio
1.29
Net debt/EBITDA
1.26
Margins
EBITDA margin
40.5%
Gross margin
70.2%
Net margin
26.1%
Operating margin
34.7%
Efficiency
Return on assets
15.1%
Return on equity
45.3%
Return on invested capital
25.5%
Return on capital employed
25.9%
Return on sales
34.8%
Dividend
Dividend yield
0.79%
DPS
$1.23
Payout ratio
27.7%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
2.25%
1 week
3.58%
1 month
-1.42%
1 year
-20.1%
YTD
-36.59%
QTD
4.36%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$8B
Gross profit
$5.62B
Operating income
$2.78B
Net income
$2.09B
Gross margin
70.2%
Net margin
26.1%
The net income has grown by 9% YoY
The gross profit has grown by 9% YoY
Zoetis's operating income has increased by 8% YoY
ZTS's revenue is up by 8% YoY

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
P/E
35.01
P/B
15.9
P/S
9.1
EV/EBIT
27.53
EV/EBITDA
23.63
EV/Sales
9.57
The P/E is 26% lower than the last 4 quarters average of 46.4 and 18% lower than the 5-year quarterly average of 41.6
Zoetis's EPS has increased by 10% YoY
The stock's price to book (P/B) is 25% less than its 5-year quarterly average of 20.8 and 24% less than its last 4 quarters average of 20.5
ZTS's equity is up by 5% year-on-year
ZTS's price to sales (P/S) is 26% lower than its last 4 quarters average of 12.1 and 9% lower than its 5-year quarterly average of 9.8
ZTS's revenue is up by 8% YoY

Efficiency

How efficient is Zoetis business performance
ZTS's return on assets is up by 9% year-on-year
ZTS's ROIC is up by 9% YoY and by 2.4% QoQ
The company's return on equity fell by 6% YoY

Dividends

What is ZTS's dividend history
Dividend details
DPS
$1.23
Dividend yield
0.79%
Payout ratio
27.7%
Recent dividends

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 50% greater than its total liabilities
Zoetis's quick ratio has decreased by 44% YoY and by 10% QoQ
The company's current ratio fell by 35% YoY and by 3.1% QoQ
The debt is 47% higher than the equity
Zoetis's debt to equity has decreased by 13% YoY
The debt fell by 8% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.